Global Blood Collection Devices Market Outlook
Revenue, 2024
Forecast, 2034
CAGR, 2024 - 2034
The diagnostic process and treatment plans depend on blood collection devices which include needles and syringes and lancets and vacuum blood collection systems. Medical professionals use these devices to obtain blood samples which need testing for glucose levels and cholesterol and infectious diseases and blood disorders. The market has experienced growing interest in automated devices and safety enhanced medical equipment.
Market Key Insights
- The Blood Collection Devices market is projected to grow from $8.4 billion in 2024 to $17.5 billion in 2034. This represents a CAGR of 7.6%, reflecting rising demand across Hospitals, Nursing Homes and Ambulatory Surgical Centers.
BD, Terumo BCT Inc., and Fresenius Kabi AG are among the leading players in this market, shaping its competitive landscape.
- U.S. and Germany are the top markets within the Blood Collection Devices market and are expected to observe the growth CAGR of 4.9% to 7.3% between 2024 and 2030.
- Emerging markets including Brazil, Indonesia and South Africa are expected to observe highest growth with CAGR ranging between 8.7% to 10.5%.
Transition like Technological Advancements is expected to add $1 billion to the Blood Collection Devices market growth by 2030
- The Blood Collection Devices market is set to add $9.1 billion between 2024 and 2034, with manufacturer targeting ASCs & Nursing Homes End-user projected to gain a larger market share.
- With Rising prevalence of blood disorders, and Increasing demand for diagnostic services, Blood Collection Devices market to expand 108% between 2024 and 2034.
Opportunities in the Blood Collection Devices
The blood collection device market shows promising growth potential in emerging markets across India and China. The rising healthcare spending combined with rising preventive healthcare knowledge in these areas will also create market demand for blood collection devices.
Growth Opportunities in North America and Asia Pacific
North America Outlook
The blood collection device market in North America benefits from its well developed healthcare system and elevated healthcare spending levels. The market competition in North America remains intense because BD and Terumo BCT Inc. maintain their dominant positions in the region. The rising number of medical conditions that need blood tests and rising surgical procedures create substantial market demand for blood collection devices in this region. The market will experience its most significant expansion through automated blood collection technology development and process automation integration.
Asia Pacific Outlook
The Asia Pacific blood collection devices market experiences fast expansion because China and India along with other emerging nations drive its growth. The market competition becomes more intense because Fresenius Kabi AG and Nipro Corporation operate alongside local manufacturers. The region experiences market growth because of its expanding population and rising blood donation awareness and increasing disease prevalence. The region presents opportunities for market growth because healthcare infrastructure investments continue to rise and people need better and more efficient blood collection systems.
Market Dynamics and Supply Chain
Driver: Rising Prevalence of Infectious Diseases and Advancements in Blood Collection Technologies
The blood collection devices market also experiences growing demand because medical procedures require safe and sterile environments. Healthcare providers select high quality sterile blood collection devices because they understand the dangers of medical procedure cross contamination. The market for these devices will also experience ongoing expansion because of this developing trend.
Restraint: Stringent Regulatory Guidelines
Opportunity: Growth in Home Healthcare Services and Rising Demand for Blood Collection Devices in Diagnostic Centers
The rising number of blood tests for disease diagnosis creates a growing need for blood collection devices in diagnostic centers. The development of vacuum blood collection tubes through technological progress has improved both speed and comfort of blood collection which explains their rising usage.
Challenge: High Costs of Advanced Devices
Supply Chain Landscape
Nipro Corporation
Sarstedt
BD
Terumo BCT Inc
McKesson
Cardinal Health
Hospitals
Diagnostic Centers
Blood Banks
Nipro Corporation
Sarstedt
BD
Terumo BCT Inc
McKesson
Cardinal Health
Hospitals
Diagnostic Centers
Blood Banks
Applications of Blood Collection Devices in Hospitals, Nursing Homes & Ambulatory Surgical Centers
The main customers of blood collection devices operate at hospitals because they need vacuum blood collection devices for their efficient and convenient operation. The devices serve three main purposes in medical settings because they perform routine blood tests and preoperative tests and patient health monitoring. The major company BD offers an extensive selection of these devices because they maintain exceptional quality standards and deliver dependable results.
The fast and non invasive nature of capillary blood collection devices makes them suitable for ASCs to perform their procedures. The devices serve patients who have trouble getting venous access including elderly patients and children. Terumo BCT Inc. stands as a top manufacturer of capillary blood collection devices because they create products that combine advanced design with user friendly functionality.
The nursing home environment requires blood collection devices like lancets because patient comfort stands as their main priority. The devices enable healthcare providers to perform blood draws with minimal pain which suits the needs of elderly patients. Fresenius Kabi AG operates as a leading company which provides differents of easy to use lancets for medical use.
Recent Developments
BD introduced blood collection devices with new technology which provides better accuracy and improved patient comfort.
Terumo BCT Inc. expanded its worldwide operations through establishing a new European manufacturing facility which increased its blood collection devices production capacity.
Fresenius Kabi AG formed a joint venture with a major medical devices company to develop new blood collection devices.
Grifols S.A. launched a new blood collection device which minimizes the chances of contamination.
Nipro Corporation bought a startup which focused on blood collection technology development to enhance its market presence.
The blood collection device market has experienced substantial expansion because of technological progress and rising diagnostic service requirements. The market has experienced a transformation through new devices including vacuum blood collection tubes and lancets and blood collection needles which enhance blood sampling procedures through better efficiency and precision. The market experiences growing demand for early disease detection because infectious diseases continue to spread at higher rates.